Rowlatt Robotics
Unified Predictive Intelligence for Biopharma and Edge Autonomy
About
our Company
Rowlatt Robotics engineers predictive AI built on a unified cognitive architecture. Designed for multi-system adaptation across biological and cyber-physical environments, it acts as a singular cognitive engine functioning autonomously or integrating into a wider platform.Within Biopharma we accelerate the drug discovery pipeline. By focusing on predictive molecular interactions and advanced candidate filtering, our models are built to de-risk early-stage development and rapidly identify viable therapeutic pathways for enterprise pipelines. Beyond the laboratory, the underlying probabilistic reasoning that powers our biotech engine is adaptable to the physical world. We leverage this architecture to create robust, ultra-efficient control frameworks for advanced edge robotics, enabling autonomous decision-making in decentralized and unpredictable environments.While our underlying technology is complex, our philosophy is simple: we build intelligent, scalable systems that turn prediction into progress.
Current Focus
Rowlatt Robotics is currently in active research and development. Our immediate focus is architecting and stress-testing the computational frameworks of our core engine. By prioritizing robust virtual modeling at this stage, we are ensuring our underlying architecture is highly scalable for complex, enterprise-level deployment.We are actively building our network ahead of our next growth phase. We welcome conversations with forward-thinking researchers, industry peers, and potential corporate partners.
Jack Rowlatt
Founder | Computational Systems Biologist | PhD Candidate
Jack Rowlatt is the founder and lead systems architect at Rowlatt Robotics. His work represents the culmination of a career spent navigating complex digital, financial, and biological systems. A former enterprise systems engineer and independent market analyst, Jack pivoted into the life sciences to solve deeper challenges surrounding the limitations of biology.Separately from his work at Rowlatt Robotics, Jack is completing a PhD at Griffith University, bringing together computational systems biology and experimental biochemistry. His academic research centres on developing a predictive multi-omics platform to identify and prioritise disease-associated patterns in glycobiology. When he is not in the lab or architecting software, Jack can often be found cycling on the coast or designing small-scale robotics in his home workshop.Rowlatt Robotics grew from Jack’s conviction that intelligent systems should not merely understand the world as it is, but anticipate what it might become. At the heart of that vision lies a simple principle: prediction does not eliminate complexity; it gives us a way to navigate it. Through predictive computational science, Jack aims to turn that principle into practical technologies that transform dense, complex biological and spatial data into actionable foresight.
Contact Us
Reach out below.
Text